ASND (Ascendis Pharma AS) Inventories, Finished Goods: $0 Mil (As of Mar. 2026)


ASND Ascendis Pharma AS ASND
37 GF Score
Price $274.50
! 1 Warning Sign
View Full Analysis

What is Ascendis Pharma AS Inventories, Finished Goods?

Ascendis Pharma AS ASND +2.52% 37 Inventories, Finished Goods is $0 Mil as of Mar. 2026. GuruFocus rates ASND with a GF Score™ of 37/100. The stock has 1 warning sign investors should review.

Ascendis Pharma AS's quarterly finished goods increased from Sep. 2025 ($0 Mil) to Dec. 2025 ($34 Mil) but then declined from Dec. 2025 ($34 Mil) to Mar. 2026 ($0 Mil).

Ascendis Pharma AS's annual finished goods increased from Dec. 2023 ($21 Mil) to Dec. 2024 ($44 Mil) but then declined from Dec. 2024 ($44 Mil) to Dec. 2025 ($34 Mil).

Ascendis Pharma AS Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Ascendis Pharma AS's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ascendis Pharma AS Inventories, Finished Goods Chart

Ascendis Pharma AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.85 0.00 21.09 44.32 33.91

Ascendis Pharma AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 33.91 0.00
ASND
37GF Score
Ascendis Pharma AS ASND
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ascendis Pharma AS Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of $0 Mil mean?
Ascendis Pharma AS (ASND) has a Inventories, Finished Goods of $0 Mil as of Mar. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on Ascendis Pharma AS and its competitors.
Is Ascendis Pharma AS's Inventories, Finished Goods too high?
Ascendis Pharma AS's current Inventories, Finished Goods is $0 Mil. Overall, Ascendis Pharma AS has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Ascendis Pharma AS's Inventories, Finished Goods compare to JAZZ and BBIO?
Ascendis Pharma AS's Inventories, Finished Goods of $0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Biotechnology company?
A good Inventories, Finished Goods depends on the Biotechnology industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Ascendis Pharma AS and its competitors. Ascendis Pharma AS's current Inventories, Finished Goods is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ascendis Pharma AS stock overvalued right now?
Ascendis Pharma AS (ASND) has a current Inventories, Finished Goods of $0 Mil. The current Inventories, Finished Goods is $0 Mil. Ascendis Pharma AS's overall GF Score™ is 37/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Ascendis Pharma AS (ASND), the current Inventories, Finished Goods is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ascendis Pharma AS Business Description

Other Exchanges A1SN34:Brazil
Address Tuborg Boulevard 12, Hellerup, DNK, 2900
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
37GF Score

Get the complete analysis for ASND

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$274.50
Price